Bone Biologics Corp - Warrants (13/10/2026)
BBLGW
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.83M
Close$
$2.19
86.3% downside
Current Fair Value
86.3% downsideOvervalued by 86.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.83 Million |
|---|---|
| Enterprise Value | $-1,704,061.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | 0.53 |
| Outstanding Shares | 1,795,260 |
Return
| Return on Equity | -61.20% |
|---|---|
| Return on Assets | -57.40% |
| Return on Invested Capital | -62.03% |
Valuation & Multiples
| P/E Ratio | -0.53 |
|---|---|
| PEG | 2.14 |
| Price to Sales | - |
| Price to Book Ratio | 8.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.59 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bone Biologics Corp
2 employees